The most interesting anecdote in here is when the now-former Juul CEO described the Altria investment in terms of the smoker database the partnership would provide. 17M smokers in Altria's database. https://www.youtube.com/watch?v=dZ3y_MuCirQ …
It's that database, and that path it represents, in which Altria gained control of Juul. What was originally viewed as merely an investment, now appears differently through this desperate reshuffle. They see combustion's end, and Juul's deep margin. https://www.nytimes.com/2019/09/25/health/juul-vaping.html …
On one hand, good, but I can only imagine e-cigarette users consume vastly more nicotine, and I'm not sure we understand what that will mean. It would seem that the history of stimulants only goes one direction: up. On a longer horizon, what endocrine problems await this species?
I wrote more about stimulants here in the context of Juul, focussing on young people and digital culture:
You can follow @_DanielSinclair.
Tip: mention @threader_app on a Twitter thread with the keyword “compile” to get a link to it.
Enjoy Threader? Sign up.
Threader is an independent project created by only two developers. The site gets 500,000+ visits a month and our iOS Twitter client was featured as an App of the Day by Apple. Running this space is expensive and time consuming. If you find Threader useful, please consider supporting us to make it a sustainable project.